Your browser is no longer supported. Please, upgrade your browser.
VIVO Meridian Bioscience, Inc. monthly Stock Chart
VIVO [NASD]
Meridian Bioscience, Inc.
Index- P/E48.78 EPS (ttm)0.50 Insider Own0.90% Shs Outstand42.83M Perf Week-2.65%
Market Cap1.06B Forward P/E25.04 EPS next Y0.97 Insider Trans15.11% Shs Float42.31M Perf Month-0.78%
Income21.40M PEG2.87 EPS next Q0.23 Inst Own84.10% Short Float6.27% Perf Quarter48.56%
Sales204.00M P/S5.20 EPS this Y10.10% Inst Trans-1.44% Short Ratio3.16 Perf Half Y189.51%
Book/sh4.78 P/B5.08 EPS next Y28.82% ROA6.50% Target Price26.50 Perf Year126.16%
Cash/sh1.14 P/C21.37 EPS next 5Y17.00% ROE10.90% 52W Range5.51 - 26.51 Perf YTD148.62%
Dividend- P/FCF38.83 EPS past 5Y-7.30% ROI9.60% 52W High-8.37% Beta0.94
Dividend %- Quick Ratio2.50 Sales past 5Y1.30% Gross Margin58.50% 52W Low340.83% ATR1.53
Employees660 Current Ratio3.60 Sales Q/Q14.10% Oper. Margin14.40% RSI (14)53.78 Volatility6.95% 5.95%
OptionableYes Debt/Eq0.00 EPS Q/Q31.90% Profit Margin10.50% Rel Volume1.21 Prev Close26.41
ShortableYes LT Debt/Eq0.24 EarningsAug 07 BMO Payout0.00% Avg Volume839.13K Price24.29
Recom1.30 SMA20-0.48% SMA5015.89% SMA20093.48% Volume1,040,753 Change-8.03%
Jul-27-20Initiated H.C. Wainwright Buy $34
May-11-20Upgrade William Blair Mkt Perform → Outperform
May-01-19Upgrade Piper Jaffray Underweight → Neutral $15 → $11
Apr-03-19Downgrade Canaccord Genuity Hold → Sell $17 → $11
Jan-26-18Reiterated Canaccord Genuity Hold $14 → $16
Mar-28-17Initiated CL King Neutral
Mar-28-16Reiterated Canaccord Genuity Hold $18 → $19
Sep-10-15Reiterated Canaccord Genuity Hold $19 → $18
Jul-27-15Reiterated Canaccord Genuity Hold $20 → $19
May-04-15Reiterated Canaccord Genuity Hold $19 → $20
Nov-06-14Downgrade Robert W. Baird Outperform → Neutral $22 → $22
Jul-27-12Downgrade Canaccord Genuity Buy → Hold
Apr-25-11Upgrade Wedbush Underperform → Neutral $18 → $22
Mar-24-11Upgrade Canaccord Genuity Hold → Buy $30
Nov-16-10Initiated Canaccord Genuity Hold $21
Apr-07-10Initiated Wedbush Underperform $18
Nov-13-09Reiterated Caris & Company Average $21 → $20
Jul-07-09Initiated Caris & Company Average $21
Mar-06-09Initiated William Blair Mkt Perform
Oct-14-08Initiated Lazard Capital Buy $30
Aug-07-20 07:30AM  
Aug-06-20 04:00PM  
Aug-05-20 09:42AM  
Jul-31-20 05:45PM  
12:30PM  
Jul-28-20 10:24AM  
09:00AM  
Jul-27-20 09:33AM  
Jul-16-20 09:00AM  
Jul-13-20 01:57PM  
01:00PM  
Jul-10-20 11:30AM  
Jul-01-20 09:37AM  
Jun-30-20 09:56AM  
Jun-29-20 08:09AM  
Jun-24-20 11:18AM  
Jun-22-20 11:59AM  
Jun-18-20 09:15AM  
Jun-15-20 03:51PM  
May-29-20 08:00AM  
May-26-20 08:00AM  
May-20-20 04:20PM  
May-12-20 04:20PM  
May-09-20 08:01PM  
May-08-20 08:55AM  
08:02AM  
07:30AM  
May-06-20 05:51PM  
08:00AM  
May-01-20 12:30PM  
Apr-30-20 10:51AM  
Apr-27-20 11:56AM  
Apr-16-20 09:00AM  
Apr-15-20 12:23PM  
Apr-14-20 09:34AM  
Apr-02-20 10:11AM  
07:30AM  
Mar-16-20 11:51AM  
08:00AM  
07:15AM  
Mar-13-20 03:27PM  
Mar-04-20 04:56PM  
Feb-26-20 02:24PM  
08:00AM  
Feb-24-20 12:18PM  
Feb-20-20 10:25AM  
Feb-19-20 01:16PM  
09:15AM  
Feb-11-20 08:01AM  
Feb-07-20 08:45AM  
07:30AM  
Jan-31-20 12:30PM  
Jan-28-20 02:23PM  
Jan-27-20 01:19PM  
09:17AM  
Jan-23-20 08:00AM  
Jan-21-20 10:11AM  
Jan-15-20 04:30PM  
Dec-30-19 12:48PM  
Dec-20-19 02:40PM  
Dec-11-19 09:49AM  
Nov-15-19 02:39PM  
Nov-14-19 01:08PM  
Nov-07-19 09:15AM  
07:30AM  
Nov-06-19 07:30AM  
Oct-31-19 03:50PM  
10:34AM  
Oct-30-19 05:21PM  
Oct-16-19 11:00AM  
Oct-04-19 01:13PM  
Aug-28-19 07:07AM  
Aug-23-19 09:30AM  
Aug-10-19 08:34AM  
Jul-30-19 02:23PM  
08:55AM  
07:30AM  
Jul-23-19 10:32AM  
Jul-10-19 04:30PM  
Jul-02-19 07:25AM  
Jun-26-19 09:30PM  
Jun-04-19 10:34AM  
Jun-03-19 04:28PM  
May-20-19 01:42PM  
May-09-19 08:45PM  
May-03-19 02:21AM  
Apr-30-19 11:50AM  
10:38AM  
10:15AM  
10:10AM  
09:42AM  
09:41AM  
09:08AM  
Apr-23-19 10:32AM  
Apr-19-19 10:43AM  
Apr-18-19 08:48AM  
Apr-10-19 04:55PM  
Apr-02-19 06:59AM  
Mar-27-19 12:03PM  
Mar-15-19 10:03AM  
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for various gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms and technologies, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; rapid fluorescence-based immunoassay platform under the Curian brand; rapid single-use immunoassays under the ImmunoCard and ImmunoCard STAT! brand names; enzyme-linked immunoassays under the PREMIER brand; and anodic stripping voltammetry, an electrical chemical sensor platform for quantitative determination under the LeadCare and PediaStat brands. This segment's products are primarily used in the detection of infectious diseases caused by various bacteria, viruses, parasites, and pathogens. Its products consists of gastrointestinal assays, including tests for C. difficile, Enterohemorrhagic E. coli, Campylobacter jejuni, H. pylori, Cryptosporidium, giardia lamblia, and calprotectin; respiratory illness assays, such as tests for Group A Streptococcus, Influenza, M. pneumoniae, Bordetella pertussis, and respiratory syncytial virus; blood chemistry assays; and tests for Group B Streptococcus, Chlamydia trachomatis, Neisseria gonorrhea, Herpes Simplex Virus Type 1 and Type 2, and Malaria. This segment sells its products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by researchers, agri-bio companies, and IVD manufacturing companies. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Baldasare Bryan TExec VP & CFOJun 30Option Exercise19.711,50029,56554,137Jul 02 01:52 PM
Williams FeliciaDirectorMar 16Buy6.021,5509,3315,717Mar 17 01:55 PM
Kenny John P.Chief Executive OfficerMar 12Buy5.7830,000173,541238,324Mar 13 09:05 AM
Baldasare Bryan TExec VP & CFOMar 10Buy6.972,00013,93652,637Mar 11 01:47 PM
McIlwraith JohnDirectorFeb 25Buy7.595,00037,95017,167Feb 26 09:01 AM
Rice John McCune Jr.DirectorFeb 24Buy7.523,00022,54712,167Feb 26 08:51 AM
Kenny John P.Chief Executive OfficerFeb 21Buy7.6510,00076,546208,324Feb 24 11:01 AM
PHILLIPS DAVIDDirectorNov 12Buy8.0610,00080,62648,616Nov 13 10:49 AM
Kenny John P.Chief Executive OfficerNov 08Buy7.7320,000154,588198,324Nov 12 08:08 AM